Orlistat

Nisha K. Patel, PharmD, Alona Crowder, Pharm.D., Reza Alavi, M.D.
Orlistat is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Xenical (Prescription Strength): Obesity management including weight loss and weight maintenance in patients with a body mass index (BMI) ≥ 30 kg/m2 OR ≥ 27 kg/m2 in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).
  • Alli (OTC Strength): Obesity management in overweight adults (18 years and older) when used along with a reduced-calorie and low-fat diet

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Xenical (Prescription Strength): Obesity management including weight loss and weight maintenance in patients with a body mass index (BMI) ≥ 30 kg/m2 OR ≥ 27 kg/m2 in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).
  • Alli (OTC Strength): Obesity management in overweight adults (18 years and older) when used along with a reduced-calorie and low-fat diet

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: June 4, 2019